Advertisement
Screener

Skye Bioscience, Inc. (SKYE) Income (Loss) from Continuing Operations before Income Taxes, Domestic

1.5 / 5 stars · 13/42 Roast Me

Skye Bioscience, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic

Skye Bioscience, Inc. (SKYE) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$56.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-10

  • Skye Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$56.24M.
  • Skye Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$27.50M.
  • Skye Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$25.80M.
  • Skye Bioscience, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$18.80M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31-$56.24M
10-K · filed 2026-03-10
2024-12-31-$27.50M
10-K · filed 2026-03-10
2023-12-31-$25.80M
10-K · filed 2025-03-20
2022-12-31-$18.80M
10-K · filed 2024-03-22
2021-12-31-$8.45M
10-K · filed 2023-03-31
2020-12-31-$6.56M
10-K · filed 2022-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
HYPERION DEFI, INC. (HYPD)United States$0.065B
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
XBiotech Inc. (XBIT)United States$0.066B-1.56
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99